Clinical Trials
37 trialsNCT03426371 2026-05-12
Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 3 Terminated
NCT05328908 2025-08-13
RELATIVITY-123
Bristol-Myers Squibb
Phase 3 Terminated
NCT01167725 2024-12-27
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT04607668 2024-11-26
PRESERVE1
G1 Therapeutics, Inc.
Phase 3 Terminated
NCT05223673 2024-08-20
COLSTAR
Servier
Phase 3 Terminated
NCT03500874 2024-01-22
Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM
Sun Yat-sen University
Phase 3 Terminated
NCT01011478 2023-08-16
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
NSABP Foundation Inc
Phase 3 Terminated
NCT00002525 2023-06-28
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
Eastern Cooperative Oncology Group
Phase 3 Terminated
NCT03678428 2023-02-16
FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
Sun Yat-sen University
Phase 3 Terminated
NCT04034355 2022-01-26
POLAR-A
Egetis Therapeutics
Phase 3 Terminated
NCT03654729 2021-12-17
POLAR-M
Egetis Therapeutics
Phase 3 Terminated
NCT01767857 2021-06-29
XCITE
Janssen Research & Development, LLC
Phase 3 Terminated
NCT01318161 2021-02-16
EPICOL
Örebro University, Sweden
Phase 3 Terminated
NCT00023868 2020-12-02
Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)
American College of Radiology Imaging Network
Phase 3 Terminated
NCT02453490 2020-07-14
Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis
Zhejiang University
Phase 3 Terminated
NCT03300609 2020-06-11
5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab
University of Southern California
Phase 3 Terminated
NCT00544700 2020-02-20
Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer
Swiss Cancer Institute
Phase 3 Terminated
NCT00078897 2019-09-24
Selenium for Prevention of Adenomatous Colorectal Polyps
University of Arizona
Phase 3 Terminated
NCT02605044 2019-02-11
Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer
AB Science
Phase 3 Terminated
NCT01842971 2018-08-02
ALPPS (Liver Partition and Portal Vein Ligation) for Two-stage Hepatectomy for Colorectal Liver Metastasis
Centre Hospitalier Universitaire, Amiens
Phase 3 Terminated
NCT00077233 2018-05-16
FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT01279681 2017-12-08
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT01939223 2017-10-20
COAST
Bayer
Phase 3 Terminated
NCT01309126 2017-07-13
PRIMUS
HiberCell, Inc.
Phase 3 Terminated
NCT02060669 2017-04-27
Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer
Samsung Medical Center
Phase 3 Terminated
NCT01233544 2016-05-12
RAS01
University of Aarhus
Phase 3 Terminated
NCT00603577 2016-05-05
XENON
Sanofi
Phase 3 Terminated
NCT00305643 2015-12-24
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00396487 2015-06-11
Tailored Treatment in Metastatic Colorectal Cancer
Vejle Hospital
Phase 3 Terminated
NCT00720512 2015-03-11
BEBYP
Gruppo Oncologico del Nord-Ovest
Phase 3 Terminated
NCT00394992 2014-02-04
Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer
Dutch Colorectal Cancer Group
Phase 3 Terminated
NCT00268463 2013-05-15
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
NSABP Foundation Inc
Phase 3 Terminated
NCT01189227 2013-05-10
Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
NSABP Foundation Inc
Phase 3 Terminated
NCT00087256 2013-01-07
Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
NSABP Foundation Inc
Phase 3 Terminated
NCT00387348 2012-12-03
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
Massachusetts General Hospital
Phase 3 Terminated
NCT00006269 2012-05-25
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
Novartis
Phase 3 Terminated
NCT01437826 2011-09-21
Antioxidant Supplement and Reduction of Metachronous Adenomas of the Large Bowel: a Double Blind Randomized Trial
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Phase 3 Terminated